Compare up to 4 stocks side by side, across all 7 of StockIQ's scoring categories.
| Category | TSHA Taysha Gene Therapies, Inc. | AAPG Ascentage Pharma Group International - American Depository |
|---|---|---|
| Price | $4.74 -2.7% | $15.90 -2.5% |
| StockIQ Score | 41D Weak Risk: Medium | 41D Weak Risk: High |
| Technical | 23F | 36F |
| Fundamental | 34F | 35F |
| Growth | 45D+ | 50C- |
| Fair Value | 38F | 38F |
| News | 74B | 50C- |
| Quality | 63C+ | 50C- |
| Risk | 46D+ | 40D |
Scores are based on real financial data only and do not constitute investment advice. How the score is calculated
Both stocks share the same weak rating and investor score of 41, so they’re tied in overall investor perception. AAPG outperforms TSHA in growth (50 vs. 45) and technicals (36 vs. 23), while TSHA leads slightly in fundamentals (34 vs. 35). Valuation scores are equal at 38, making AAPG stronger in growth and technical strength.
